The week in review


Chris Freeman, Mark Coulton, Richard Colbeck and Mark Kinsela at the launch on Wednesday.
Chris Freeman, Mark Coulton, Richard Colbeck and Mark Kinsela at the launch on Wednesday.

It’s been a busy week at the Pharmacy Guild, plus there’s been scrutiny on aged care and non-pharmacist ownership models

The Fair Work Commission released documents showing that we’re now in the final stage proceedings of the four yearly review of the Pharmacy Industry Award 2010, with the Guild and Professionals Australia set to meet soon.

Meanwhile the Pharmacy Guild says it is meeting with the Pharmaceutical Benefits Advisory Committee to discuss 60-day scripts, with national president George Tambassis calling on Guild members to help it oppose the proposal. The Guild and Mr Tambassis also came under scrutiny from Crikey Inq, which characterised payments to pharmacy under the CPAs as “rivers of gold”.

Queensland Health Minister Steven Miles announced an expansion of pharmacist vaccination in that state in a move welcomed by the PSA and Guild. The Pharmaceutical Society launched its report into medicines safety in the residential aged care setting: highlighting a host of problems. We took a look at opioid prescribing over the last 25 years.

The Guild’s Anthony Tassone has condemned the deregulated US pharmacy ownership regulations, in the light of allegations by Walgreens employees that their concerns about stress, errors and the skirting of safety protocols weren’t addressed.

Researchers called for a national health strategy on bushfire smoke; we reported on complaints about IV therapy; and AHPRA launched a new strategy for cultural safety in the health system.

The Guild’s Suzanne Greenwood wrote of how pharmacy and the Primary Health Networks solved a communication problem over face masks. And following feedback that pharmacists are having a tough time and feel they’re not treated with respect, PDL and the Guild got together to launch a resource to help.

Previous A flawed agenda
Next Clinical tips: Medicinal cannabis

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.